SymBiosis Capital Partners, LLC 13D/13G Filings for Rani Therapeutics Holdings, Inc. (RANI)

SymBiosis Capital Partners, LLC 13D and 13G filings for Rani Therapeutics Holdings, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-02-12
1:45 pm
Purchase
2025-11-1313GRani Therapeutics Holdings, Inc.
RANI
SymBiosis Capital Partners, LLC6,300,000
6.500%
6,300,000increase
(New Position)
Filing